OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug discovery and development: introduction to the general public and patient groups
Natesh Singh, Philippe Vayer, Shivalika Tanwar, et al.
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Current status and trends in small nucleic acid drug development: Leading the future
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 13

Evolving Paradigms of Recombinant Protein Production in Pharmaceutical Industry: A Rigorous Review
Achuth Jayakrishnan, Wan Rosalina Wan Rosli, Ahmad Rashidi Mohamed Tahir, et al.
Sci (2024) Vol. 6, Iss. 1, pp. 9-9
Open Access | Times Cited: 12

Industry 4.0 technologies adoption for digital transition in drug discovery and development: A review
Amit Anthwal, Akshat Uniyal, Jitender Gairolla, et al.
Journal of Industrial Information Integration (2024) Vol. 38, pp. 100562-100562
Closed Access | Times Cited: 9

How many subjects are enough in a veterinary trial?—Literature review and insights from industrial statisticians
Zikun Wang, Qi Cao, Qingzhi Liu, et al.
Research in Veterinary Science (2025) Vol. 186, pp. 105569-105569
Open Access | Times Cited: 1

Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials
Cindy Hoi Ting Yeung, Ruud H J Verstegen, Rachel G. Greenberg, et al.
Frontiers in Pediatrics (2024) Vol. 11
Open Access | Times Cited: 5

Farmasi Cerdas: Era Baru Penemuan Obat dengan AI dan Big Data
Raymond R. Tjandrawinata
MEDICINUS (2025) Vol. 38, Iss. 1, pp. 27-36
Closed Access

The discovery of a new uncompetitive inhibitor of nucleoside hydrolase from Leishmania donovani
Marina Amaral Alves, Thamires Rocco Machado, Luis Gabriel Valdivieso Gelves, et al.
Bioorganic Chemistry (2025), pp. 108209-108209
Closed Access

ADMET Prediction Compounds of Polar Extract Curcuma rhizoma
Sumardi Sumardi, Suprianto Suprianto, Sepridawati Siregar, et al.
Jurnal Indah Sains dan Klinis (2025) Vol. 5, Iss. 3, pp. 01-08
Closed Access

Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models
Dewald Steyn, Anja Haasbroek‐Pheiffer, Wihan Pheiffer, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 195-195
Open Access

Essential database resources for modern drug discovery
S. K. Yadav, Sweta S Koka, Priya Jain, et al.
Advances in pharmacology (2025)
Closed Access

Advances in bioinformatic methods for the acceleration of the drug discovery from nature
Magdalena Maciejewska‐Turska, Milen I. Georgiev, Guoyin Kai, et al.
Phytomedicine (2025) Vol. 139, pp. 156518-156518
Closed Access

DeSAO: A new approach for De Novo Drug using Simulated Annealing Optimization
Rosalvo Ferreira de Oliveira Neto, Murilo Boratto, Edilson Beserra de Alencar Filho
Expert Systems with Applications (2025), pp. 127099-127099
Closed Access

Preclinical In Vivo Animal Xenograft Models: Heterogeneity and Biomarkers of Therapeutic Response and Resistance
Mohamed Y. Zaky, Nahed S. Lamloum, Noha A. Ahmed, et al.
(2025), pp. 109-127
Closed Access

Unravelling the epigenetic based mechanism in discovery of anticancer phytomedicine: Evidence based studies
Bushra Bashir, Pranshul Sethi, Satyajit Panda, et al.
Cellular Signalling (2025), pp. 111743-111743
Closed Access

GraphBAN: An inductive graph-based approach for enhanced prediction of compound-protein interactions
Hamid Hadipour, Yan Yi Li, Yan Sun, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

The interaction of Orthoflavivirus nonstructural proteins 3 and 5 with human fatty acid synthase
Suthatta Sornprasert, Wannapa Sornjai, Duncan R. Smith
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319207-e0319207
Open Access

In silico discovery of novel compounds for FAK activation using virtual screening, AI-based prediction, and molecular dynamics
D. Y. Yoon, Hyunsu Lee
Computational Biology and Chemistry (2025), pp. 108420-108420
Closed Access

Geographic disparities in gastrointestinal oncology research: a focus on trial availability in Italy
Maurizio Polignano, Nicola Carella, Ornella Rotolo, et al.
The Oncologist (2025) Vol. 30, Iss. 3
Open Access

Recent Advances in Vitamin E TPGS-Based Organic Nanocarriers for Enhancing the Oral Bioavailability of Active Compounds: A Systematic Review
Chee‐Yin Wong, Siew-Keah Lee, Yang Mooi Lim, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 485-485
Open Access

When the drugs (don’t) work: The role of science in product commercialization
Paul‐Emmanuel Anckaert
Research Policy (2025) Vol. 54, Iss. 5, pp. 105237-105237
Open Access

UHPLC and Computational Studies of Chemical Constituents Derived from Myrica esculenta against NADPH Oxidase 2 (NOX2) Protein
Amit Ranjan Pandey, Waseem Ahmad Ansari, Priyanka Maurya, et al.
ChemistrySelect (2025) Vol. 10, Iss. 14
Closed Access

Recent Uses of FT-IR, Raman, and Near Infrared Spectroscopy (NIRS) in Drug Discovery
Neeraj Kumar, Girish Chandra Sharma, Arti Sharma, et al.
Advances in chemical and materials engineering book series (2025), pp. 133-150
Closed Access

Techniques and Strategies in Drug Design and Discovery
George Mihai Niţulescu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1364-1364
Open Access | Times Cited: 4

3D bioprinting for the construction of drug testing models-development strategies and regulatory concerns
Divya Mallya, Mrunmayi Gadre, S. Varadharajan, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access

Novel drug discovery strategies for chronic obstructive pulmonary disease: the latest developments
Luigino Calzetta, Elena Pistocchini, Shima Gholamalishahi, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-10
Closed Access

Page 1 - Next Page

Scroll to top